Journal
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume 91, Issue 3, Pages 226-228Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2018.02.013
Keywords
CXCL13; Borrelia burgdorferi; point-of-care test; Lyme neuroborreliosis
Categories
Funding
- Jane and Aatos Erkko Foundation
- Reagena
Ask authors/readers for more resources
Cerebrospinal fluid chemokine (C-X-C motif) ligand 13 (CXCL13) is a marker for Lyme neuroborreliosis (LNB). CXCL13 lateral flow immunoassay (LFA) was compared with CXCL13 ELISA. CXCL13 LFA results correlated strongly with CXCL13 ELISA results. CXCL13 LFA is a rapid and easy-to-perform test, which is suitable for routine point-of-care diagnostics of suspected LNB patients. (C) 2018 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
